Abstract
C19H15BrFeO, orthorhombic, P212121 (no. 19), a = 5.7615(2) Å, b = 10.5534(4) Å, c = 25.7793(10) Å, V = 1567.47(10) Å3, Z = 4, Rgt(F) = 0.0399 wRref(F2) = 0.0861, T = 170 K.
The molecular structure is shown in the figure. Table 1 contains the crystallographic data and the list of the atoms including atomic coordinates and displacement parameters can be found in the cif-file attached to this article.

Data collection and handling.
| Crystal: | Red block |
| Size: | 0.12 × 0.06 × 0.05 mm |
| Wavelength: | MoKα radiation (0.71073 Å) |
| μ: | 3.51 mm−1 |
| Diffractometer, scan mode: | Bruker Apex-II, φ and ω scans |
| θmax, completeness: | 28.5°, 100 % |
| N(hkl)measured, N(hkl)unique, Rint: | 12190, 3935, 0.072 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2σ(Iobs), 3,006 |
| N(param)refined: | 199 |
| Programs: | Bruker, 1 Shelx, 2 , 3 Olex2 4 |
1 Source of materials
The 3-bromobenzaldehyde (3.68 g, 20.0 mmol), acetylferrocene (2.28 g, 10.0 mmol) and KOH (0.67 g, 12.0 mmol) were added to the mortar. After stirring well, the reaction mixture was ground for 20 min, until the TLC indicated the reaction was completed, then diluted with water and filtered. The solid was collected and washed with water, and dried overnight under vacuum. The crude product was further purified by flash silica chromatography to afford a single crystal of high quality. For crystal growth, the crude product was dissolved in a minimal amount of hot ethanol and slowly cooled to room temperature.
2 Experimental details
The crystal structure was solved via Direct Methods employing SHELXT, 2 followed by anisotropic refinement of non-hydrogen atoms using full-matrix least-squares calculations (SHELXL, 3 ) within the Olex2 platform. 4
3 Comment
The elucidation of crystal structures in ferrocene derivatives is pivotal for understanding their supramolecular organization, which governs bulk physicochemical properties such as charge transport, thermal stability, and solubility. 5 , 6 , 7 Precise crystallographic analysis reveals intermolecular interactions that dictate packing motifs, while also confirming regioselectivity and stereochemical fidelity in synthetic designs. 8 , 9 , 10
The molecular architecture of (E)-(3-(3-bromophenyl)acryloyl)ferrocene features a central ferrocene core comprising an iron atom (Fe1) coordinated symmetrically between two cyclopentadienyl (Cp) rings. The left Cp ring remains unsubstituted, preserving its planar aromatic character, 11 , 12 , 13 , 14 , 15 while the right Cp ring is functionalized with an acryloyl moiety extending into a propenoyl chain. This chain terminates at the C8 position of the acryloyl unit with a 3-bromophenyl substituent, introducing steric and electronic asymmetry. The acryloyl bridge adopts an E configuration at the C7=C8 double bond, as confirmed by the antiperiplanar arrangement of the carbonyl oxygen (O1) and the brominated phenyl group.
The stereochemical rigidity of the E-configured acryloyl group enforces a planar geometry across the conjugated system, facilitating electronic communication between the electron-withdrawing bromophenyl group and the electron-rich ferrocene core. The 3-bromophenyl substituent, positioned orthogonally to the Cp rings, introduces significant steric bulk, likely influencing π-π stacking interactions and solubility properties. 16 , 17 , 18 This structural duality (planar aromatic cores vs. flexible substituents) suggests tailored applications in catalysis or materials science, where tunable electronic and steric profiles are critical.
All geometric parameters are in the expected ranges for such complexes containing a halogenophenyl moiety. 11 , 14 , 19
-
Research funding: This work was financially supported by the projects of Natural Science Foundation of Shannxi Province (2023-YBSF-009, 2024JC-YBMS-733), the Scientific research plan project of Shaanxi Provincial Department of Education (24JK0334), the 2023 research and development project of the Xianyang Science and Technology Bureau (L2023-ZDYF-SF-030), Key Laboratory of Molecular Imaging and Drug Synthesis of Xianyang city (2021QXNL-PT-0008), School-level Scientific and Technological Innovation Team for Design, Synthesis and Structural Modification of Drug Molecules (2024KCTD04).
References
1. Bruker. Saint, Apex2 and Sadabs; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar
2. Sheldrick, G. M. Shelxt – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8.10.1107/S2053273314026370Search in Google Scholar PubMed PubMed Central
3. Sheldrick, G. M. Crystal Structure Refinement with Shelxl. Acta Crystallogr. 2015, C71, 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central
4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A.; Puschmann, H. Olex2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
5. Artigas, V.; González, D.; Fuentealba, M. Syntheses, Characterisation and Crystal Structures of Ferrocenyl β-diketones and Their Schiff Base NNO Ligand Derivatives with 2-Picolylamine. J. Mol. Struct. 2017, 1129, 325–332.10.1016/j.molstruc.2016.09.009Search in Google Scholar
6. Shi, Y.-C.; Yang, H.-M.; Shen, W.-B.; Yan, C.-G.; Hu, X.-Y. Syntheses and Crystal Structures of Ferrocene-Containing Enaminones and Their Copper Complexes. Polyhedron 2004, 23, 15–21; https://doi.org/10.1016/j.poly.2003.08.017.Search in Google Scholar
7. Celedon, S.; Fuentealba, M.; Roisnel, T.; Hamon, J.-R.; Carrillo, D.; Manzur, C. Stepwise Construction of a 4-hydroxyphenyl Functionalized O,N,N-Tridentate Ferrocene-Containing Enaminone: Spectral, Analytical and Structural Studies. Inorg. Chim. Acta 2012, 390, 184–189; https://doi.org/10.1016/j.ica.2012.04.028.Search in Google Scholar
8. Tang, W.; Gao, Y.; Tong, H.; Xu, X.; Zhu, Z.; Liu, B. Green Synthesis of Ferrocenyl Chalcones Against Triple Negative Breast Cancer. J. Organomet. Chem. 2023, 989, 122640; https://doi.org/10.1016/j.jorganchem.2023.122640.Search in Google Scholar
9. Delavaux-Nicot, B.; Maynadié, J.; Lavabre, D.; Lepetit, C.; Donnadieu, B. The First X-ray Characterized Monosubstituted Ferrocenyl Azacrown Chalcone: Focus on its Calcium Interaction/Electrochemical Detection Studies. Eur. J. Inorg. Chem. 2005, 2005, 2493–2505.10.1002/ejic.200400781Search in Google Scholar
10. Muškinja, J.; Burmudžija, A.; Ratković, Z.; Ranković, B.; Kosanić, M.; Bogdanović, G. A.; Novaković, S. B. Ferrocenyl Chalcones with O-alkylated Vanillins: Synthesis, Spectral Characterization, Microbiological Evaluation, and Single-Crystal X-ray Analysis. Med. Chem. Res. 2016, 25, 1744–1753; https://doi.org/10.1007/s00044-016-1609-8.Search in Google Scholar
11. Li, X.; Dang, X.; Yu, J.Liu, B. Crystal Structure of(4-(4-Chlorophenyl)-1H-Pyrrole-3-Carbonyl)Ferrocene, C21H16ClFeNO. Z. Kristallogr. N. Cryst. Struct. 2025, 240, 415–417; https://doi.org/10.1515/ncrs-2025-0034.Search in Google Scholar
12. Otano Vega, M. R.; Rivero, K. I.; Montes Gonzalez, I. (E)-1-Ferrocenyl-3-(2-Methoxyphenyl)Prop-2-en-1-one. Acta Crystallogr. Sect. E 2014, 70, m108–m109; https://doi.org/10.1107/s1600536814003912.Search in Google Scholar PubMed PubMed Central
13. Allison, M.; Caramés-Méndez, P.; Hofmann, B. J.; Pask, C. M.; Phillips, R. M.; Lord, R. M.; McGowan, P. C. Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands. Organometallics 2023, 42, 1869–1881; https://doi.org/10.1021/acs.organomet.2c00553.Search in Google Scholar PubMed PubMed Central
14. Zhang, L.; Xie, M. The Crystal Structure of (E)-3-(2-Chlorophenyl)-1-Ferrocenylprop-2-en-1-one, C19H15ClFeO. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 531–533; https://doi.org/10.1515/ncrs-2022-0042.Search in Google Scholar
15. Zhang, J.; Hu, X.; Liu, X.; He, Y. The Crystal Structure of (E)-1-Ferrocenyl-3-(4-Isopropylphenyl)Prop-2-en-1-one, C22H22FeO. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 437–439; https://doi.org/10.1515/ncrs-2022-0063.Search in Google Scholar
16. Anizaim, A. H.; Zainuri, D. A.; Zaini, M. F.; Razak, I. A.; Bakhtiar, H.; Arshad, S. Comparative Analyses of New Donor-π-Acceptor Ferrocenyl-Chalcones Containing Fluoro and Methoxy-Fluoro Acceptor Units as Synthesized Dyes for Organic Solar Cell Material. PLoS One 2020, 15, e0241113; https://doi.org/10.1371/journal.pone.0241113.Search in Google Scholar PubMed PubMed Central
17. Allison, M.; Caramés-Méndez, P.; Pask, C. M.; Phillips, R. M.; Lord, R. M.; McGowan, P. C. Bis(Bipyridine)Ruthenium(II) Ferrocenyl β-Diketonate Complexes: Exhibiting Nanomolar Potency Against Human Cancer Cell Lines. Chem. – Eur. J. 2021, 27, 3737–3744.10.1002/chem.202004024Search in Google Scholar PubMed
18. Vázquez-Bravo, J.; Aguilar-Marcelino, L.; Castañeda-Ramírez, G. S.; De los Santos-Pérez, I.; Arroyo-Carmona, R. E.; Bernès, S.; Hernández-Pareja, U.; Gómez-Rodríguez, O.; Rosas-Saito, G. H.. J. Helminthol. 2020, 94, E190; https://doi.org/10.1017/S0022149X2000070X.Search in Google Scholar PubMed
19. Tang, W.; Gao, Y.; Xu, X.; Zhu, Z. Crystal Structure of((4-(4-Bromophenyl)-1H-Pyrrole-3-yl)Methyl)Ferrocene, C21H16BrFeNO. Z. Kristallogr. N. Cryst. Struct. 2025, 240, 447–449; https://doi.org/10.1515/ncrs-2025-0049.Search in Google Scholar
© 2025 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of (S)-N-(10-((2,2-dimethoxyethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide, C25H32N2O7
- The crystal structure of 6,6′-difluoro-3,3′-dimethyl-5,5′-di(10H-phenoxazin-10-yl)- [1,1′-biphenyl]-2,2′-dicarbonitrile, C40H24F2N4O2
- Crystal structure of poly[(di-ethylenediamine-κ2N,N′)cadmium(II) tetradedocyloxidohexavanadate] (V4+/V5+ = 2/1), C4H16CdN4O14V6
- The crystal structure of poly[bis(dimethylformamide-κ1N)-(μ4-2′,3,3″,5′-tetrakis(trifluoromethyl)-[1,1′:4′,1″-terphenyl]-4,4″-dicarboxylato-κ4 O,O′: O″,O‴)dicadmium(II)], C27H15CdF12NO5
- Crystal structure of bis(μ2-ferrocenylcarboxylato-O,O′)-(μ3-oxido-κ3O:O:O)-bis(μ2-salicyladoximato-κ2N,O,O′)-(μ2-isopropoxo)-tris(isopropoxy-κ1O trititanium(IV)), C48H55N2O13Fe2Ti3
- Crystal structure of 3-(diethylamino)-7,9,11-trimethyl-8-phenyl-6H,13H-12λ4,13λ4-chromeno[3′,4′:4,5]pyrrolo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-one, C28H26BF2N3O2
- The crystal structure of catena-poly[aqua-μ2-2-nitro-benzene-1,3-dicarboxylato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)-zinc(II)], C20H13N3O7Zn
- Crystal structure of poly[diaqua-{μ3-1-(3-carboxylatophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylato-κ4O,O′:O′′:O′′′′}manganese(II)] hydrate
- Crystal structure of N′-((1-hydroxycyclohexyl)(phenyl)methyl)-2-methoxybenzohydrazide methanol solvate, C22H28N2O4
- The cocrystal of caffeic acid — progesterone — water (1/2/1), C51H70O9
- Crystal structure of (((oxido(quinolin-6-yl)methoxy)triphenyl-λ5-stibanyl)oxy)(quinolin-7-yl)methanolate
- Crystal structure of [(E)-6′-(diethylamino)-2-(2-(((E)-pyren-1-ylmethylene)amino)ethyl)-4′-(2-((E)-1,3,3-trimethylindolin-2-ylidene)ethylidene)-1′,2′,3′,4′-tetrahydrospiro[isoindoline-1,9′-xanthen]-3-one]-methanol, solvate C57H56N4O3
- The crystal structure of 1-(acridin-9-yl)pyrrolidine-2,5-dione, C17H22N2O2
- Crystal structure of N-(4-acetylphenyl)-2-(6-methoxynaphthalen-2-yl)propanamide, C22H21NO3
- The crystal structure of 5,10,15,20-tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)porphyrin, C52H34N16
- Crystal structure of hexacarbonyl-μ2-[phenylmethanedithiolato-κ4S:S,S′:S′]diiron (Fe–Fe) C13H6Fe2O6S2
- Crystal structure of diiodo-bis(1-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ1N)cadmium(II), C34H34CdI2N10
- Crystal structure of (E)-(3-(3-bromophenyl)acryloyl)ferrocene, C19H15BrFeO
- Crystal structure of catena-poly(μ2-6-chloropyridine-2-carboxylato-κ3N,O:O′)(6-chloropyridine-2-carboxylato-κ2O,N)copper(II), C12H6Cl2N2O4Cu
- Crystal structure of poly[diaqua-μ3-(5-(3,5-dicarboxy-2,4,6-trimethylbenzyl)-2,4,6-trimethylisophthalato)-κ6O,O′:O″,O‴:O‴′,O‴″) terbium(III)-monohydrate], C23H28TbO12
- Crystal structure of (E)-2-(((5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene)amino)-3′,6′-dihydroxyspiro[isoindoline-1,9′-xanthen]-3-one – ethanol (1/2), C35H33ClN4O6
- The crystal structure of 3-(5-amino-3-phenylisoxazol-4-yl)-4-chloro-3-hydroxyindolin-2-one, C17H12ClN3O3
- The crystal structure of dimethylammonium 4-[2-(4-fluorophenyl)-4, 5-diphenyl-1H-imidazol-1-yl]benzenesulfonate, C29H26FN3O3S
- Crystal structure of (R)-2-ammonio-3-((5-carboxypentyl)thio)propanoate
- Crystal structure of 4-cyclohexyl-5-(thiophen-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C12H15N3S2
- The crystal structure of 4,6-bis(dimethylamino)-2-fluoroisophthalonitrile, C12H13FN4
- Hydrogen bonding in the crystal structure of nicotin-1,1′-dium tetrabromidomanganate(II)
- The crystal structure of bis(2-bromobenzyl)(2-((2-oxybenzylidene)amino)-4-methylpentanoato-κ3N, O,O′)tin(IV), C27H27Br2NO3Sn
- Crystal structure of (E)-(3-(p-tolyl)acryloyl)ferrocene, C20H18FeO
- Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C21H22FN3O
- Crystal structure of (E)-7-methoxy-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C22H25N3O2
- The crystal structure of poly(bis(μ2-1,3,5-tri(1H-imidazol-1-yl)benzene-κ2N:N′)-(μ2-2,3,5,6-tetrafluoroterephthalato-κ2O:O′)-manganese(II), C38H24F4N12O4Mn
- Crystal structure of (3,4-dimethoxybenzyl)triphenylphosphonium bromide ethanol solvate, C29H32BrO3P
- Crystal structure of tetraethylammonium hydrogencarbonate – (diaminomethylene)thiourea – water (2/1/3)
- Crystal structure of N, N-Dimethyl-N′-tosylformimidamide, C10H14N2O2S
- The crystal structure of ethyl 2-methyl-5-oxo-4-(2-methoxyphenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H23N2O4
- Crystal structure of bis(μ2-1,5-bis[(E)-1-(2-hydroxyphenyl)ethylidene] thiocarbonohydrazide)-bis(dimethylformamide)-dizinc(II) dimethylformamide solvate, C40H46N10O6S2Zn2⋅C3H7NO
- Crystal structure of azido-κ1N{hydridotris(3-tert-butyl-5-methylpyrazol-1-yl)borato-κ3N,N′,N″}copper(II), C24H40BCuN9
- The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(azido-κ1N)rhenium(I), C15H8N5O3Re
- Crystal structure of 4-((triphenylphosphonio)methyl)pyridin-1-ium tetrachloridozincate(II), C24H22Cl4NPZn
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of (S)-N-(10-((2,2-dimethoxyethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide, C25H32N2O7
- The crystal structure of 6,6′-difluoro-3,3′-dimethyl-5,5′-di(10H-phenoxazin-10-yl)- [1,1′-biphenyl]-2,2′-dicarbonitrile, C40H24F2N4O2
- Crystal structure of poly[(di-ethylenediamine-κ2N,N′)cadmium(II) tetradedocyloxidohexavanadate] (V4+/V5+ = 2/1), C4H16CdN4O14V6
- The crystal structure of poly[bis(dimethylformamide-κ1N)-(μ4-2′,3,3″,5′-tetrakis(trifluoromethyl)-[1,1′:4′,1″-terphenyl]-4,4″-dicarboxylato-κ4 O,O′: O″,O‴)dicadmium(II)], C27H15CdF12NO5
- Crystal structure of bis(μ2-ferrocenylcarboxylato-O,O′)-(μ3-oxido-κ3O:O:O)-bis(μ2-salicyladoximato-κ2N,O,O′)-(μ2-isopropoxo)-tris(isopropoxy-κ1O trititanium(IV)), C48H55N2O13Fe2Ti3
- Crystal structure of 3-(diethylamino)-7,9,11-trimethyl-8-phenyl-6H,13H-12λ4,13λ4-chromeno[3′,4′:4,5]pyrrolo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-one, C28H26BF2N3O2
- The crystal structure of catena-poly[aqua-μ2-2-nitro-benzene-1,3-dicarboxylato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)-zinc(II)], C20H13N3O7Zn
- Crystal structure of poly[diaqua-{μ3-1-(3-carboxylatophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylato-κ4O,O′:O′′:O′′′′}manganese(II)] hydrate
- Crystal structure of N′-((1-hydroxycyclohexyl)(phenyl)methyl)-2-methoxybenzohydrazide methanol solvate, C22H28N2O4
- The cocrystal of caffeic acid — progesterone — water (1/2/1), C51H70O9
- Crystal structure of (((oxido(quinolin-6-yl)methoxy)triphenyl-λ5-stibanyl)oxy)(quinolin-7-yl)methanolate
- Crystal structure of [(E)-6′-(diethylamino)-2-(2-(((E)-pyren-1-ylmethylene)amino)ethyl)-4′-(2-((E)-1,3,3-trimethylindolin-2-ylidene)ethylidene)-1′,2′,3′,4′-tetrahydrospiro[isoindoline-1,9′-xanthen]-3-one]-methanol, solvate C57H56N4O3
- The crystal structure of 1-(acridin-9-yl)pyrrolidine-2,5-dione, C17H22N2O2
- Crystal structure of N-(4-acetylphenyl)-2-(6-methoxynaphthalen-2-yl)propanamide, C22H21NO3
- The crystal structure of 5,10,15,20-tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)porphyrin, C52H34N16
- Crystal structure of hexacarbonyl-μ2-[phenylmethanedithiolato-κ4S:S,S′:S′]diiron (Fe–Fe) C13H6Fe2O6S2
- Crystal structure of diiodo-bis(1-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ1N)cadmium(II), C34H34CdI2N10
- Crystal structure of (E)-(3-(3-bromophenyl)acryloyl)ferrocene, C19H15BrFeO
- Crystal structure of catena-poly(μ2-6-chloropyridine-2-carboxylato-κ3N,O:O′)(6-chloropyridine-2-carboxylato-κ2O,N)copper(II), C12H6Cl2N2O4Cu
- Crystal structure of poly[diaqua-μ3-(5-(3,5-dicarboxy-2,4,6-trimethylbenzyl)-2,4,6-trimethylisophthalato)-κ6O,O′:O″,O‴:O‴′,O‴″) terbium(III)-monohydrate], C23H28TbO12
- Crystal structure of (E)-2-(((5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene)amino)-3′,6′-dihydroxyspiro[isoindoline-1,9′-xanthen]-3-one – ethanol (1/2), C35H33ClN4O6
- The crystal structure of 3-(5-amino-3-phenylisoxazol-4-yl)-4-chloro-3-hydroxyindolin-2-one, C17H12ClN3O3
- The crystal structure of dimethylammonium 4-[2-(4-fluorophenyl)-4, 5-diphenyl-1H-imidazol-1-yl]benzenesulfonate, C29H26FN3O3S
- Crystal structure of (R)-2-ammonio-3-((5-carboxypentyl)thio)propanoate
- Crystal structure of 4-cyclohexyl-5-(thiophen-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C12H15N3S2
- The crystal structure of 4,6-bis(dimethylamino)-2-fluoroisophthalonitrile, C12H13FN4
- Hydrogen bonding in the crystal structure of nicotin-1,1′-dium tetrabromidomanganate(II)
- The crystal structure of bis(2-bromobenzyl)(2-((2-oxybenzylidene)amino)-4-methylpentanoato-κ3N, O,O′)tin(IV), C27H27Br2NO3Sn
- Crystal structure of (E)-(3-(p-tolyl)acryloyl)ferrocene, C20H18FeO
- Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C21H22FN3O
- Crystal structure of (E)-7-methoxy-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C22H25N3O2
- The crystal structure of poly(bis(μ2-1,3,5-tri(1H-imidazol-1-yl)benzene-κ2N:N′)-(μ2-2,3,5,6-tetrafluoroterephthalato-κ2O:O′)-manganese(II), C38H24F4N12O4Mn
- Crystal structure of (3,4-dimethoxybenzyl)triphenylphosphonium bromide ethanol solvate, C29H32BrO3P
- Crystal structure of tetraethylammonium hydrogencarbonate – (diaminomethylene)thiourea – water (2/1/3)
- Crystal structure of N, N-Dimethyl-N′-tosylformimidamide, C10H14N2O2S
- The crystal structure of ethyl 2-methyl-5-oxo-4-(2-methoxyphenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H23N2O4
- Crystal structure of bis(μ2-1,5-bis[(E)-1-(2-hydroxyphenyl)ethylidene] thiocarbonohydrazide)-bis(dimethylformamide)-dizinc(II) dimethylformamide solvate, C40H46N10O6S2Zn2⋅C3H7NO
- Crystal structure of azido-κ1N{hydridotris(3-tert-butyl-5-methylpyrazol-1-yl)borato-κ3N,N′,N″}copper(II), C24H40BCuN9
- The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(azido-κ1N)rhenium(I), C15H8N5O3Re
- Crystal structure of 4-((triphenylphosphonio)methyl)pyridin-1-ium tetrachloridozincate(II), C24H22Cl4NPZn